Nektar Therapeutics (NASDAQ:NKTR)

3.06
Delayed Data
As of Sep 27
 -0.02 / -0.65%
Today’s Change
3.00
Today|||52-Week Range
19.37
-77.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues27.8M39.8M28.2M23.3M
 
 
 
 
 
Cost of Goods Sold2.1M4.4M2.4M2.0M
 
 
 
 
 
Depreciation And Amortization2.7M3.1M3.1M3.1M
 
 
 
 
 
 
Operating ExpensesGross Income23.0M32.4M22.8M18.3M
 
 
 
 
 
General Expenses121.6M132.7M143.5M129.3M
 
 
 
 
 
Research And Development102.9M108.9M118.5M106.7M
 
 
 
 
 
Total Operating Expenses126.4M140.1M148.9M134.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-98.6M-100.3M-120.7M-111.0M
 
 
 
 
 
Interest Expense On Debt10.3M11.8M11.3M11.2M
 
 
 
 
 
Other Expenses11.8M12.0M12.5M12.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-97.0M-100.1M-119.5M-110.2M
 
 
 
 
 
Income Taxes-900.0K-1.8M-983.0K-278.0K
 
 
 
 
 
Net Income-96.1M-98.2M-118.5M-109.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS172.7M173.3M173.9M174.5M
 
 
 
 
 
Shares To Calculate EPS Diluted172.7M173.3M173.9M174.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56-$0.57-$0.68-$0.63
 
 
 
 
 
EPS Diluted-$0.56-$0.57-$0.68-$0.63